Skanska USA Commercial Development Announces $70M Life Science Development in Cambridge’s Kendall Square

Press release 9/27/2011 12:00 AM EST

Skanska USA’s Commercial Development business unit in Boston announced the investment of $70 million in a laboratory and office building located at 150 Second Street in Cambridge.  The project is Skanska’s first commercial real estate investment in Cambridge, home to the world’s leading biotechnology and technology innovation center, Kendall Square.